Coverage for High‐Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|6|1474-1480

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.6, 2015-06, pp. : 1474-1480

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage

By Cisternas Miriam G.   Foreman Aimee J.   Marshall Thomas S.   Runken M. Chris   Kobashi Kathleen C.   Seifeldin Raafat  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 911-919

Informa Healthcare

Access to resources Recommend Favorite

Use and Spending for Biologic Disease‐Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 9, 2015-09 ,pp. : 1210-1218

John Wiley & Sons Inc

Access to resources Recommend Favorite

Societal cost of rheumatoid arthritis patients in the US

By Birnbaum Howard   Pike Crystal   Kaufman Rebecca   Maynchenko Maryna   Kidolezi Yohanne   Cifaldi Mary  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 77-90

Informa Healthcare

Access to resources Recommend Favorite

Medicare Coverage in the Nursing Home

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 37, Iss. 8, 1989-08 ,pp. : 774-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations*

By Nair Kavita V.   Tang Boxiong   Bos Jill Van Den   Zhang Vicki   Saseen Joseph J.   Naim Ahmad   Rahman Mirza  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 303-314

Informa Healthcare

Access to resources Recommend Favorite